Format
Sort by
Items per page

Send to

Choose Destination

Best matches for alzheimer's epha1:

Search results

Items: 1 to 20 of 46

1.

Whole Exome Sequencing of an Exceptional Longevity Cohort.

Nygaard HB, Erson-Omay EZ, Wu X, Kent BA, Bernales CQ, Evans DM, Farrer MJ, Vilariño-Güell C, Strittmatter SM.

J Gerontol A Biol Sci Med Sci. 2018 May 10. doi: 10.1093/gerona/gly098. [Epub ahead of print]

PMID:
29750252
2.

Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.

Liu G, Zhang Y, Wang L, Xu J, Chen X, Bao Y, Hu Y, Jin S, Tian R, Bai W, Zhou W, Wang T, Han Z, Zong J, Jiang Q.

J Alzheimers Dis. 2018;61(3):1077-1088. doi: 10.3233/JAD-170468.

PMID:
29332039
3.

Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function.

Cukier HN, Kunkle BK, Hamilton KL, Rolati S, Kohli MA, Whitehead PL, Jaworski J, Vance JM, Cuccaro ML, Carney RM, Gilbert JR, Farrer LA, Martin ER, Beecham GW, Haines JL, Pericak-Vance MA.

J Alzheimers Dis Parkinsonism. 2017 Aug;7(4). pii: 355. doi: 10.4172/2161-0460.1000355. Epub 2017 Jul 31.

4.

Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.

Huovinen J, Helisalmi S, Paananen J, Laiterä T, Kojoukhova M, Sutela A, Vanninen R, Laitinen M, Rauramaa T, Koivisto AM, Remes AM, Soininen H, Kurki M, Haapasalo A, Jääskeläinen JE, Hiltunen M, Leinonen V.

J Alzheimers Dis. 2017;60(3):1077-1085. doi: 10.3233/JAD-170583.

PMID:
28984604
5.

Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.

Andrews SJ, Das D, Anstey KJ, Easteal S.

J Alzheimers Dis. 2017;57(2):423-436. doi: 10.3233/JAD-160774.

PMID:
28269768
6.

Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population.

Lin E, Tsai SJ, Kuo PH, Liu YL, Yang AC, Kao CF.

Oncotarget. 2017 Apr 11;8(15):24077-24087. doi: 10.18632/oncotarget.15269.

7.

The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism.

Stage E, Duran T, Risacher SL, Goukasian N, Do TM, West JD, Wilhalme H, Nho K, Phillips M, Elashoff D, Saykin AJ, Apostolova LG.

Alzheimers Dement (Amst). 2016 Dec 19;5:53-66. doi: 10.1016/j.dadm.2016.12.003. eCollection 2016.

8.

ABCA7 p.G215S as potential protective factor for Alzheimer's disease.

Sassi C, Nalls MA, Ridge PG, Gibbs JR, Ding J, Lupton MK, Troakes C, Lunnon K, Al-Sarraj S, Brown KS, Medway C, Clement N, Lord J, Turton J, Bras J, Almeida MR; ARUK Consortium, Holstege H, Louwersheimer E, van der Flier WM, Scheltens P, Van Swieten JC, Santana I, Oliveira C, Morgan K, Powell JF, Kauwe JS, Cruchaga C, Goate AM, Singleton AB, Guerreiro R, Hardy J.

Neurobiol Aging. 2016 Oct;46:235.e1-9. doi: 10.1016/j.neurobiolaging.2016.04.004. Epub 2016 Apr 20.

9.

Genomics of Alzheimer Disease: A Review.

Rosenberg RN, Lambracht-Washington D, Yu G, Xia W.

JAMA Neurol. 2016 Jul 1;73(7):867-74. doi: 10.1001/jamaneurol.2016.0301. Review.

PMID:
27135718
10.

Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology.

Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B.

Mol Psychiatry. 2017 Jun;22(6):874-883. doi: 10.1038/mp.2016.59. Epub 2016 Apr 26.

11.

Gene-based aggregate SNP associations between candidate AD genes and cognitive decline.

Nettiksimmons J, Tranah G, Evans DS, Yokoyama JS, Yaffe K.

Age (Dordr). 2016 Apr;38(2):41. doi: 10.1007/s11357-016-9885-2. Epub 2016 Mar 22. Review.

12.

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Rosenberger AF, Hilhorst R, Coart E, García Barrado L, Naji F, Rozemuller AJ, van der Flier WM, Scheltens P, Hoozemans JJ, van der Vies SM.

J Alzheimers Dis. 2016;49(4):927-43. doi: 10.3233/JAD-150429.

13.

Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease.

Villegas-Llerena C, Phillips A, Garcia-Reitboeck P, Hardy J, Pocock JM.

Curr Opin Neurobiol. 2016 Feb;36:74-81. doi: 10.1016/j.conb.2015.10.004. Epub 2015 Oct 24. Review.

PMID:
26517285
14.

Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci.

Vardarajan BN, Ghani M, Kahn A, Sheikh S, Sato C, Barral S, Lee JH, Cheng R, Reitz C, Lantigua R, Reyes-Dumeyer D, Medrano M, Jimenez-Velazquez IZ, Rogaeva E, St George-Hyslop P, Mayeux R.

Ann Neurol. 2015 Sep;78(3):487-98. doi: 10.1002/ana.24466. Epub 2015 Jul 28.

15.

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Bohm C, Chen F, Sevalle J, Qamar S, Dodd R, Li Y, Schmitt-Ulms G, Fraser PE, St George-Hyslop PH.

Mol Cell Neurosci. 2015 May;66(Pt A):3-11. doi: 10.1016/j.mcn.2015.02.016. Epub 2015 Mar 4. Review.

16.

A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application.

Ge T, Nichols TE, Ghosh D, Mormino EC, Smoller JW, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Apr 1;109:505-514. doi: 10.1016/j.neuroimage.2015.01.029. Epub 2015 Jan 16.

17.

Genetics of Alzheimer's disease.

Chouraki V, Seshadri S.

Adv Genet. 2014;87:245-94. doi: 10.1016/B978-0-12-800149-3.00005-6. Review.

PMID:
25311924
18.

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4.

19.

Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Wang HF, Tan L, Hao XK, Jiang T, Tan MS, Liu Y, Zhang DQ, Yu JT; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;44(1):115-23. doi: 10.3233/JAD-141488.

PMID:
25182741
20.

Genetic determinants of disease progression in Alzheimer's disease.

Wang X, Lopez OL, Sweet RA, Becker JT, DeKosky ST, Barmada MM, Demirci FY, Kamboh MI.

J Alzheimers Dis. 2015;43(2):649-55. doi: 10.3233/JAD-140729.

Supplemental Content

Loading ...
Support Center